Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 15, 2007

Pfizer Animal Health Gains Access to Crucell’s PER.C6

  • Crucell and Pfizer Animal Health signed  a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.

    Pfizer Animal Health has an option to convert the research license into a commercial agreement.

  • You’re all set! Thank you for subscribing to GEN Highlights.